CORRECTION article

Front. Pharmacol., 18 April 2024

Sec. Pharmacology of Anti-Cancer Drugs

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1363218

Corrigendum: Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 axis and P-Glycoprotein transporters in lung cancer cells

  • 1. The Second Hospital of Jilin University, Changchun, China

  • 2. College of Basic Medical Sciences, Dalian Medical University, Dalian, China

  • 3. Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China

  • 4. Institute of Zoology, University of the Punjab, Lahore, Pakistan

  • 5. Medical Toxicology Laboratory, Department of Zoology, Women University of Azad Jammu and Kashmir, Muzaffarabad, Pakistan

  • 6. Faculty of Rehabilitation and Allied Health Sciences, Riphah International University, Islamabad, Pakistan

  • 7. Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, China

Article metrics

View details

1,2k

Views

519

Downloads

In the published article, there was an error in Figures 5B,C as published. The striatum of Figures 5B,C in the article was not the final version. This may have been caused by an initial error in the image layout editing process. The molecular docking presentation in Figure 5B is duplicate of Figure 5A while Figure 5C is pasted incorrectly, however, the description of Figure 5 in the article is correct. The corrected Figure 5 and its caption appear below.

FIGURE 5

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

paclitaxel resistance, STAT3, FUT4, P-gp, MALAT1, alantolactone, brevilin A

Citation

Ding Y, Zhen Z, Nisar MA, Ali F, Din RU, Khan M, Mughal TA, Alam G, Liu L and Saleem MZ (2024) Corrigendum: Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 axis and P-Glycoprotein transporters in lung cancer cells. Front. Pharmacol. 15:1363218. doi: 10.3389/fphar.2024.1363218

Received

30 December 2023

Accepted

08 April 2024

Published

18 April 2024

Volume

15 - 2024

Edited and reviewed by

Olivier Feron, Université catholique de Louvain, Belgium

Updates

Copyright

*Correspondence: Linlin Liu, ; Muhammad Zubair Saleem, ,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics